These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29480994)

  • 1. Impact of Cyclin D1 and Heterogeneous Nuclear Ribonucleoprotein-K (HnRNP-K) on Urinary Bladder Carcinogenesis.
    Aboushousha T; Hammam O; Helal N; El Dahshan S
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):513-519. PubMed ID: 29480994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
    Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Cyclin D1 in Urothelial Carcinoma of Urinary Bladder and its Association with Tumour Grade.
    Nahar R; Jinnah MSA; Karim SS; Alam MM; Khatun J; Kabir E; Aktar M
    Mymensingh Med J; 2024 Apr; 33(2):461-465. PubMed ID: 38557526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical Expression of Cyclin D1, Cytokeratin 20, and Uroplakin III in Proliferative Urinary Bladder Lesions Induced by o-Nitroanisole in Fischer 344/N Rats.
    Willson CJ; Flake GP; Sills RC; Kissling GE; Cesta MF
    Vet Pathol; 2016 May; 53(3):682-90. PubMed ID: 26319780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
    Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
    IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.
    Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
    Luo HB; Li B; Yuan WG; Xu CR
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer.
    Fristrup N; Birkenkamp-Demtröder K; Reinert T; Sanchez-Carbayo M; Segersten U; Malmström PU; Palou J; Alvarez-Múgica M; Pan CC; Ulhøi BP; Borre M; Ørntoft TF; Dyrskjøt L
    Am J Pathol; 2013 Feb; 182(2):339-49. PubMed ID: 23201130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.
    Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F
    Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma.
    Phoomak C; Park D; Silsirivanit A; Sawanyawisuth K; Vaeteewoottacharn K; Detarya M; Wongkham C; Lebrilla CB; Wongkham S
    Mol Oncol; 2019 Feb; 13(2):338-357. PubMed ID: 30444036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD10 and E-cad expression in urinary bladder urothelial and squamous cell carcinoma.
    Omran OM
    J Environ Pathol Toxicol Oncol; 2012; 31(3):203-12. PubMed ID: 23339695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of cyclin D1, HER2, and AMACR expressions with histologic grade in bladder urothelial carcinomas.
    Karakaya YA; Oral E
    Indian J Pathol Microbiol; 2021; 64(1):84-90. PubMed ID: 33433414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.
    Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
    Urol Oncol; 2007; 25(6):468-75. PubMed ID: 18047954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of replication protein A (RPA) expression levels in bladder urothelial carcinoma.
    Levidou G; Gakiopoulou H; Kavantzas N; Saetta AA; Karlou M; Pavlopoulos P; Thymara I; Diamantopoulou K; Patsouris E; Korkolopoulou P
    BJU Int; 2011 Jul; 108(2 Pt 2):E59-65. PubMed ID: 21062395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p16 and cyclin D1 in bladder cancer and correlation in cancer progression.
    Yang CC; Chu KC; Chen HY; Chen WC
    Urol Int; 2002; 69(3):190-4. PubMed ID: 12372886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical demonstration of cyclin D1 in bladder cancers as an inverse indicator of invasiveness but not an independent prognostic factor.
    Takagi Y; Takashi M; Koshikawa T; Sakata T; Ohshima S
    Int J Urol; 2000 Oct; 7(10):366-72. PubMed ID: 11144504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced immunohistochemical PTEN staining is associated with higher progression rate and recurrence episodes in non-invasive low-grade papillary urothelial carcinoma of the bladder.
    Kulac I; Arslankoz S; Netto GJ; Ertoy Baydar D
    Virchows Arch; 2018 Jun; 472(6):969-974. PubMed ID: 29368083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and discrimination of preneoplastic and early stages of lung adenocarcinoma using hnRNP B1 combined with the cell cycle-related markers p16, cyclin D1, and Ki-67.
    Tominaga M; Sueoka N; Irie K; Iwanaga K; Tokunaga O; Hayashi S; Nakachi K; Sueoka E
    Lung Cancer; 2003 Apr; 40(1):45-53. PubMed ID: 12660006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclin d1 and its association with disease characteristics in bladder cancer.
    Kopparapu PK; Boorjian SA; Robinson BD; Downes M; Gudas LJ; Mongan NP; Persson JL
    Anticancer Res; 2013 Dec; 33(12):5235-42. PubMed ID: 24324055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.